nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramipril—Nateglinide—type 2 diabetes mellitus	0.249	1	CrCtD
Ramipril—type 1 diabetes mellitus—type 2 diabetes mellitus	0.202	0.727	CtDrD
Ramipril—ACE—type 2 diabetes mellitus	0.0904	1	CbGaD
Ramipril—coronary artery disease—type 2 diabetes mellitus	0.0474	0.171	CtDrD
Ramipril—hypertension—type 2 diabetes mellitus	0.0283	0.102	CtDrD
Ramipril—Mitiglinide—Nateglinide—type 2 diabetes mellitus	0.0262	0.169	CrCrCtD
Ramipril—Cilazapril—Nateglinide—type 2 diabetes mellitus	0.0227	0.146	CrCrCtD
Ramipril—Lisinopril—Nateglinide—type 2 diabetes mellitus	0.0227	0.146	CrCrCtD
Ramipril—Spirapril—Nateglinide—type 2 diabetes mellitus	0.0227	0.146	CrCrCtD
Ramipril—ACE—Losartan—type 2 diabetes mellitus	0.0222	0.146	CbGbCtD
Ramipril—SLC15A2—Chlorpropamide—type 2 diabetes mellitus	0.022	0.145	CbGbCtD
Ramipril—Enalapril—Nateglinide—type 2 diabetes mellitus	0.0213	0.137	CrCrCtD
Ramipril—Trandolapril—Nateglinide—type 2 diabetes mellitus	0.0213	0.137	CrCrCtD
Ramipril—SLC15A2—Tolbutamide—type 2 diabetes mellitus	0.0197	0.129	CbGbCtD
Ramipril—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.019	0.125	CbGbCtD
Ramipril—Aspartame—Nateglinide—type 2 diabetes mellitus	0.018	0.116	CrCrCtD
Ramipril—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0169	0.111	CbGbCtD
Ramipril—SLC15A2—Nateglinide—type 2 diabetes mellitus	0.0167	0.11	CbGbCtD
Ramipril—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0144	0.0947	CbGbCtD
Ramipril—SLC15A2—Glyburide—type 2 diabetes mellitus	0.0113	0.0743	CbGbCtD
Ramipril—SLC15A1—Glyburide—type 2 diabetes mellitus	0.00972	0.064	CbGbCtD
Ramipril—ACE—arteriole—type 2 diabetes mellitus	0.00246	0.157	CbGeAlD
Ramipril—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.00216	0.138	CbGeAlD
Ramipril—ACE—tunica intima—type 2 diabetes mellitus	0.00175	0.111	CbGeAlD
Ramipril—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.00157	0.1	CbGeAlD
Ramipril—ACE—autonomic nervous system—type 2 diabetes mellitus	0.00106	0.0673	CbGeAlD
Ramipril—ACE—hindlimb—type 2 diabetes mellitus	0.000976	0.0622	CbGeAlD
Ramipril—ACE—peripheral nervous system—type 2 diabetes mellitus	0.000762	0.0485	CbGeAlD
Ramipril—ACE—artery—type 2 diabetes mellitus	0.000599	0.0381	CbGeAlD
Ramipril—ACE—nerve—type 2 diabetes mellitus	0.000594	0.0378	CbGeAlD
Ramipril—ACE—endothelium—type 2 diabetes mellitus	0.000506	0.0322	CbGeAlD
Ramipril—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000323	0.0206	CbGeAlD
Ramipril—SLC15A1—kidney—type 2 diabetes mellitus	0.000284	0.0181	CbGeAlD
Ramipril—ACE—nephron tubule—type 2 diabetes mellitus	0.000232	0.0148	CbGeAlD
Ramipril—SLC15A2—retina—type 2 diabetes mellitus	0.000214	0.0137	CbGeAlD
Ramipril—ACE—cardiovascular system—type 2 diabetes mellitus	0.000208	0.0133	CbGeAlD
Ramipril—ACE—kidney—type 2 diabetes mellitus	0.000203	0.013	CbGeAlD
Ramipril—SLC15A2—nephron tubule—type 2 diabetes mellitus	0.000202	0.0129	CbGeAlD
Ramipril—ACE—cortex of kidney—type 2 diabetes mellitus	0.000198	0.0126	CbGeAlD
Ramipril—ACE—adipose tissue—type 2 diabetes mellitus	0.000183	0.0117	CbGeAlD
Ramipril—SLC15A1—liver—type 2 diabetes mellitus	0.000179	0.0114	CbGeAlD
Ramipril—SLC15A2—kidney—type 2 diabetes mellitus	0.000177	0.0113	CbGeAlD
Ramipril—SLC15A2—cortex of kidney—type 2 diabetes mellitus	0.000173	0.011	CbGeAlD
Ramipril—Mitiglinide—ABCC8—type 2 diabetes mellitus	0.000172	0.132	CrCbGaD
Ramipril—BCHE—nephron tubule—type 2 diabetes mellitus	0.000171	0.0109	CbGeAlD
Ramipril—BCHE—cardiovascular system—type 2 diabetes mellitus	0.000154	0.00979	CbGeAlD
Ramipril—BCHE—adipose tissue—type 2 diabetes mellitus	0.000135	0.00863	CbGeAlD
Ramipril—ACE—liver—type 2 diabetes mellitus	0.000129	0.0082	CbGeAlD
Ramipril—Mitiglinide—KCNJ11—type 2 diabetes mellitus	0.000121	0.0929	CrCbGaD
Ramipril—BCHE—liver—type 2 diabetes mellitus	9.5e-05	0.00605	CbGeAlD
Ramipril—Nateglinide—ABCC8—type 2 diabetes mellitus	8.76e-05	0.0671	CrCbGaD
Ramipril—Fosinopril—ACE—type 2 diabetes mellitus	8.72e-05	0.0668	CrCbGaD
Ramipril—Perindopril—ACE—type 2 diabetes mellitus	7.11e-05	0.0545	CrCbGaD
Ramipril—Spirapril—ACE—type 2 diabetes mellitus	7.03e-05	0.0539	CrCbGaD
Ramipril—Moexipril—ACE—type 2 diabetes mellitus	6.74e-05	0.0517	CrCbGaD
Ramipril—Mitiglinide—PPARG—type 2 diabetes mellitus	6.71e-05	0.0515	CrCbGaD
Ramipril—Benazepril—MTHFR—type 2 diabetes mellitus	6.68e-05	0.0512	CrCbGaD
Ramipril—Quinapril—ACE—type 2 diabetes mellitus	6.26e-05	0.048	CrCbGaD
Ramipril—Cilazapril—ACE—type 2 diabetes mellitus	6.26e-05	0.048	CrCbGaD
Ramipril—Lisinopril—ACE—type 2 diabetes mellitus	6.26e-05	0.048	CrCbGaD
Ramipril—Nateglinide—KCNJ11—type 2 diabetes mellitus	6.17e-05	0.0473	CrCbGaD
Ramipril—Trandolapril—ACE—type 2 diabetes mellitus	6.07e-05	0.0465	CrCbGaD
Ramipril—Benazepril—ACE—type 2 diabetes mellitus	5.45e-05	0.0418	CrCbGaD
Ramipril—Enalapril—ACE—type 2 diabetes mellitus	4.6e-05	0.0352	CrCbGaD
Ramipril—ACE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	3.53e-05	0.00373	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.5e-05	0.00369	CbGpPWpGaD
Ramipril—Nateglinide—PPARG—type 2 diabetes mellitus	3.42e-05	0.0262	CrCbGaD
Ramipril—ACE—Metabolism of proteins—GIP—type 2 diabetes mellitus	3.4e-05	0.00359	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—GAD2—type 2 diabetes mellitus	3.31e-05	0.00349	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	3.28e-05	0.00346	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	3.18e-05	0.00335	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—GNB3—type 2 diabetes mellitus	3.16e-05	0.00333	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.14e-05	0.00331	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.08e-05	0.00325	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PCSK2—type 2 diabetes mellitus	3.03e-05	0.00319	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	3e-05	0.00316	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.98e-05	0.00314	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.98e-05	0.00314	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.93e-05	0.00309	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	2.91e-05	0.00307	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—ABCC8—type 2 diabetes mellitus	2.9e-05	0.00306	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	2.86e-05	0.00302	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.78e-05	0.00293	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.76e-05	0.00291	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.76e-05	0.00291	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.72e-05	0.00287	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.72e-05	0.00286	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—WFS1—type 2 diabetes mellitus	2.7e-05	0.00285	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—GAD2—type 2 diabetes mellitus	2.54e-05	0.00267	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.53e-05	0.00266	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTGDS—type 2 diabetes mellitus	2.5e-05	0.00263	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—AGT—type 2 diabetes mellitus	2.46e-05	0.0026	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.43e-05	0.00256	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.43e-05	0.00256	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.43e-05	0.00256	CbGpPWpGaD
Ramipril—BCHE—Peptide hormone metabolism—LEP—type 2 diabetes mellitus	2.41e-05	0.00254	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—GPD2—type 2 diabetes mellitus	2.37e-05	0.0025	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	2.36e-05	0.00249	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.33e-05	0.00246	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.33e-05	0.00246	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.33e-05	0.00246	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.29e-05	0.00242	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—KCNJ11—type 2 diabetes mellitus	2.29e-05	0.00242	CbGpPWpGaD
Ramipril—Insomnia—Gliclazide—type 2 diabetes mellitus	2.27e-05	0.00045	CcSEcCtD
Ramipril—Shock—Valsartan—type 2 diabetes mellitus	2.27e-05	0.00045	CcSEcCtD
Ramipril—Loss of consciousness—Metformin—type 2 diabetes mellitus	2.26e-05	0.000448	CcSEcCtD
Ramipril—Nervous system disorder—Valsartan—type 2 diabetes mellitus	2.26e-05	0.000448	CcSEcCtD
Ramipril—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	2.26e-05	0.000448	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.26e-05	0.00238	CbGpPWpGaD
Ramipril—Paraesthesia—Gliclazide—type 2 diabetes mellitus	2.25e-05	0.000447	CcSEcCtD
Ramipril—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	2.25e-05	0.000447	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.25e-05	0.00237	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.25e-05	0.00237	CbGpPWpGaD
Ramipril—Tension—Losartan—type 2 diabetes mellitus	2.24e-05	0.000445	CcSEcCtD
Ramipril—Dizziness—Glimepiride—type 2 diabetes mellitus	2.24e-05	0.000444	CcSEcCtD
Ramipril—Skin disorder—Valsartan—type 2 diabetes mellitus	2.24e-05	0.000444	CcSEcCtD
Ramipril—Dysgeusia—Losartan—type 2 diabetes mellitus	2.24e-05	0.000444	CcSEcCtD
Ramipril—Dyspnoea—Gliclazide—type 2 diabetes mellitus	2.24e-05	0.000444	CcSEcCtD
Ramipril—Nervous system disorder—Orlistat—type 2 diabetes mellitus	2.23e-05	0.000443	CcSEcCtD
Ramipril—Dizziness—Sitagliptin—type 2 diabetes mellitus	2.23e-05	0.000443	CcSEcCtD
Ramipril—Agitation—Irbesartan—type 2 diabetes mellitus	2.23e-05	0.000442	CcSEcCtD
Ramipril—Somnolence—Gliclazide—type 2 diabetes mellitus	2.23e-05	0.000442	CcSEcCtD
Ramipril—Urticaria—Glyburide—type 2 diabetes mellitus	2.22e-05	0.00044	CcSEcCtD
Ramipril—Nervousness—Losartan—type 2 diabetes mellitus	2.22e-05	0.00044	CcSEcCtD
Ramipril—Angioedema—Irbesartan—type 2 diabetes mellitus	2.22e-05	0.00044	CcSEcCtD
Ramipril—Skin disorder—Orlistat—type 2 diabetes mellitus	2.21e-05	0.000439	CcSEcCtD
Ramipril—Abdominal pain—Glyburide—type 2 diabetes mellitus	2.21e-05	0.000438	CcSEcCtD
Ramipril—Dyspepsia—Gliclazide—type 2 diabetes mellitus	2.21e-05	0.000438	CcSEcCtD
Ramipril—Hyperhidrosis—Orlistat—type 2 diabetes mellitus	2.2e-05	0.000437	CcSEcCtD
Ramipril—Anorexia—Valsartan—type 2 diabetes mellitus	2.2e-05	0.000436	CcSEcCtD
Ramipril—Muscle spasms—Losartan—type 2 diabetes mellitus	2.2e-05	0.000436	CcSEcCtD
Ramipril—Asthenia—Bromocriptine—type 2 diabetes mellitus	2.19e-05	0.000435	CcSEcCtD
Ramipril—Chest pain—Metformin—type 2 diabetes mellitus	2.19e-05	0.000434	CcSEcCtD
Ramipril—Myalgia—Metformin—type 2 diabetes mellitus	2.19e-05	0.000434	CcSEcCtD
Ramipril—Malaise—Irbesartan—type 2 diabetes mellitus	2.19e-05	0.000434	CcSEcCtD
Ramipril—Vertigo—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.000432	CcSEcCtD
Ramipril—Headache—Pioglitazone—type 2 diabetes mellitus	2.18e-05	0.000432	CcSEcCtD
Ramipril—Syncope—Irbesartan—type 2 diabetes mellitus	2.18e-05	0.000432	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	2.17e-05	0.000431	CcSEcCtD
Ramipril—Leukopenia—Irbesartan—type 2 diabetes mellitus	2.17e-05	0.000431	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.17e-05	0.00229	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.17e-05	0.00229	CbGpPWpGaD
Ramipril—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	2.17e-05	0.00043	CcSEcCtD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.16e-05	0.00228	CbGpPWpGaD
Ramipril—Discomfort—Metformin—type 2 diabetes mellitus	2.16e-05	0.000429	CcSEcCtD
Ramipril—Fatigue—Gliclazide—type 2 diabetes mellitus	2.16e-05	0.000429	CcSEcCtD
Ramipril—Enalapril—CYP3A4—type 2 diabetes mellitus	2.16e-05	0.0166	CrCbGaD
Ramipril—Nausea—Glipizide—type 2 diabetes mellitus	2.16e-05	0.000428	CcSEcCtD
Ramipril—Vomiting—Glimepiride—type 2 diabetes mellitus	2.15e-05	0.000427	CcSEcCtD
Ramipril—Hypotension—Valsartan—type 2 diabetes mellitus	2.15e-05	0.000427	CcSEcCtD
Ramipril—Vomiting—Sitagliptin—type 2 diabetes mellitus	2.15e-05	0.000426	CcSEcCtD
Ramipril—Constipation—Gliclazide—type 2 diabetes mellitus	2.15e-05	0.000425	CcSEcCtD
Ramipril—Tremor—Losartan—type 2 diabetes mellitus	2.14e-05	0.000424	CcSEcCtD
Ramipril—Rash—Glimepiride—type 2 diabetes mellitus	2.14e-05	0.000424	CcSEcCtD
Ramipril—Dermatitis—Glimepiride—type 2 diabetes mellitus	2.13e-05	0.000423	CcSEcCtD
Ramipril—Loss of consciousness—Irbesartan—type 2 diabetes mellitus	2.13e-05	0.000423	CcSEcCtD
Ramipril—BCHE—Transmission across Chemical Synapses—SNAP25—type 2 diabetes mellitus	2.13e-05	0.00225	CbGpPWpGaD
Ramipril—Rash—Sitagliptin—type 2 diabetes mellitus	2.13e-05	0.000422	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.13e-05	0.00225	CbGpPWpGaD
Ramipril—Dermatitis—Sitagliptin—type 2 diabetes mellitus	2.13e-05	0.000422	CcSEcCtD
Ramipril—Headache—Glimepiride—type 2 diabetes mellitus	2.12e-05	0.000421	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.12e-05	0.00224	CbGpPWpGaD
Ramipril—Ill-defined disorder—Losartan—type 2 diabetes mellitus	2.12e-05	0.00042	CcSEcCtD
Ramipril—Cough—Irbesartan—type 2 diabetes mellitus	2.12e-05	0.00042	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—F7—type 2 diabetes mellitus	2.12e-05	0.00223	CbGpPWpGaD
Ramipril—Headache—Sitagliptin—type 2 diabetes mellitus	2.12e-05	0.00042	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	2.1e-05	0.000416	CcSEcCtD
Ramipril—Agitation—Losartan—type 2 diabetes mellitus	2.1e-05	0.000416	CcSEcCtD
Ramipril—Oedema—Metformin—type 2 diabetes mellitus	2.1e-05	0.000416	CcSEcCtD
Ramipril—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	2.09e-05	0.000415	CcSEcCtD
Ramipril—Angioedema—Losartan—type 2 diabetes mellitus	2.09e-05	0.000414	CcSEcCtD
Ramipril—Insomnia—Valsartan—type 2 diabetes mellitus	2.08e-05	0.000413	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	2.08e-05	0.000412	CcSEcCtD
Ramipril—Paraesthesia—Valsartan—type 2 diabetes mellitus	2.07e-05	0.00041	CcSEcCtD
Ramipril—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	2.07e-05	0.00041	CcSEcCtD
Ramipril—Arthralgia—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.00041	CcSEcCtD
Ramipril—Chest pain—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.00041	CcSEcCtD
Ramipril—Myalgia—Irbesartan—type 2 diabetes mellitus	2.07e-05	0.00041	CcSEcCtD
Ramipril—Shock—Metformin—type 2 diabetes mellitus	2.07e-05	0.00041	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—INS—type 2 diabetes mellitus	2.06e-05	0.00217	CbGpPWpGaD
Ramipril—Insomnia—Orlistat—type 2 diabetes mellitus	2.06e-05	0.000409	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	2.06e-05	0.00217	CbGpPWpGaD
Ramipril—Malaise—Losartan—type 2 diabetes mellitus	2.06e-05	0.000409	CcSEcCtD
Ramipril—Anxiety—Irbesartan—type 2 diabetes mellitus	2.06e-05	0.000408	CcSEcCtD
Ramipril—Hypersensitivity—Glyburide—type 2 diabetes mellitus	2.06e-05	0.000408	CcSEcCtD
Ramipril—Nervous system disorder—Metformin—type 2 diabetes mellitus	2.06e-05	0.000408	CcSEcCtD
Ramipril—Thrombocytopenia—Metformin—type 2 diabetes mellitus	2.06e-05	0.000408	CcSEcCtD
Ramipril—Dyspnoea—Valsartan—type 2 diabetes mellitus	2.05e-05	0.000408	CcSEcCtD
Ramipril—Vertigo—Losartan—type 2 diabetes mellitus	2.05e-05	0.000407	CcSEcCtD
Ramipril—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	2.05e-05	0.000407	CcSEcCtD
Ramipril—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	2.05e-05	0.000407	CcSEcCtD
Ramipril—Somnolence—Valsartan—type 2 diabetes mellitus	2.05e-05	0.000406	CcSEcCtD
Ramipril—Syncope—Losartan—type 2 diabetes mellitus	2.05e-05	0.000406	CcSEcCtD
Ramipril—Paraesthesia—Orlistat—type 2 diabetes mellitus	2.05e-05	0.000406	CcSEcCtD
Ramipril—Leukopenia—Losartan—type 2 diabetes mellitus	2.04e-05	0.000405	CcSEcCtD
Ramipril—Discomfort—Irbesartan—type 2 diabetes mellitus	2.04e-05	0.000405	CcSEcCtD
Ramipril—Skin disorder—Metformin—type 2 diabetes mellitus	2.04e-05	0.000404	CcSEcCtD
Ramipril—Hyperhidrosis—Metformin—type 2 diabetes mellitus	2.03e-05	0.000402	CcSEcCtD
Ramipril—Dyspepsia—Valsartan—type 2 diabetes mellitus	2.03e-05	0.000402	CcSEcCtD
Ramipril—Dizziness—Bromocriptine—type 2 diabetes mellitus	2.02e-05	0.000401	CcSEcCtD
Ramipril—Dry mouth—Irbesartan—type 2 diabetes mellitus	2.02e-05	0.000401	CcSEcCtD
Ramipril—Palpitations—Losartan—type 2 diabetes mellitus	2.02e-05	0.0004	CcSEcCtD
Ramipril—Nausea—Glimepiride—type 2 diabetes mellitus	2.01e-05	0.000399	CcSEcCtD
Ramipril—Loss of consciousness—Losartan—type 2 diabetes mellitus	2.01e-05	0.000398	CcSEcCtD
Ramipril—Nausea—Sitagliptin—type 2 diabetes mellitus	2.01e-05	0.000398	CcSEcCtD
Ramipril—Dyspepsia—Orlistat—type 2 diabetes mellitus	2e-05	0.000398	CcSEcCtD
Ramipril—Asthenia—Glyburide—type 2 diabetes mellitus	2e-05	0.000398	CcSEcCtD
Ramipril—Decreased appetite—Valsartan—type 2 diabetes mellitus	2e-05	0.000397	CcSEcCtD
Ramipril—Anorexia—Metformin—type 2 diabetes mellitus	2e-05	0.000397	CcSEcCtD
Ramipril—Cough—Losartan—type 2 diabetes mellitus	1.99e-05	0.000395	CcSEcCtD
Ramipril—Urticaria—Gliclazide—type 2 diabetes mellitus	1.99e-05	0.000395	CcSEcCtD
Ramipril—BCHE—Peptide hormone metabolism—IGF1—type 2 diabetes mellitus	1.99e-05	0.0021	CbGpPWpGaD
Ramipril—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.99e-05	0.000395	CcSEcCtD
Ramipril—Fatigue—Valsartan—type 2 diabetes mellitus	1.99e-05	0.000394	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.99e-05	0.00209	CbGpPWpGaD
Ramipril—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.98e-05	0.000393	CcSEcCtD
Ramipril—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.98e-05	0.000393	CcSEcCtD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.98e-05	0.00209	CbGpPWpGaD
Ramipril—Oedema—Irbesartan—type 2 diabetes mellitus	1.98e-05	0.000393	CcSEcCtD
Ramipril—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	1.98e-05	0.000393	CcSEcCtD
Ramipril—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.98e-05	0.000393	CcSEcCtD
Ramipril—Pruritus—Glyburide—type 2 diabetes mellitus	1.98e-05	0.000392	CcSEcCtD
Ramipril—Constipation—Valsartan—type 2 diabetes mellitus	1.97e-05	0.000391	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	1.97e-05	0.00208	CbGpPWpGaD
Ramipril—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.97e-05	0.00039	CcSEcCtD
Ramipril—Fatigue—Orlistat—type 2 diabetes mellitus	1.96e-05	0.000389	CcSEcCtD
Ramipril—Hypotension—Metformin—type 2 diabetes mellitus	1.96e-05	0.000389	CcSEcCtD
Ramipril—Shock—Irbesartan—type 2 diabetes mellitus	1.95e-05	0.000386	CcSEcCtD
Ramipril—Arthralgia—Losartan—type 2 diabetes mellitus	1.94e-05	0.000386	CcSEcCtD
Ramipril—Myalgia—Losartan—type 2 diabetes mellitus	1.94e-05	0.000386	CcSEcCtD
Ramipril—Chest pain—Losartan—type 2 diabetes mellitus	1.94e-05	0.000386	CcSEcCtD
Ramipril—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.94e-05	0.000385	CcSEcCtD
Ramipril—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	1.94e-05	0.000385	CcSEcCtD
Ramipril—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.94e-05	0.000385	CcSEcCtD
Ramipril—Anxiety—Losartan—type 2 diabetes mellitus	1.94e-05	0.000384	CcSEcCtD
Ramipril—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.93e-05	0.000383	CcSEcCtD
Ramipril—Rash—Bromocriptine—type 2 diabetes mellitus	1.93e-05	0.000382	CcSEcCtD
Ramipril—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.93e-05	0.000382	CcSEcCtD
Ramipril—Skin disorder—Irbesartan—type 2 diabetes mellitus	1.92e-05	0.000382	CcSEcCtD
Ramipril—Discomfort—Losartan—type 2 diabetes mellitus	1.92e-05	0.000381	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.92e-05	0.00202	CbGpPWpGaD
Ramipril—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.91e-05	0.00038	CcSEcCtD
Ramipril—Headache—Bromocriptine—type 2 diabetes mellitus	1.91e-05	0.00038	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.91e-05	0.000379	CcSEcCtD
Ramipril—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.91e-05	0.000379	CcSEcCtD
Ramipril—Dry mouth—Losartan—type 2 diabetes mellitus	1.9e-05	0.000377	CcSEcCtD
Ramipril—Anorexia—Irbesartan—type 2 diabetes mellitus	1.89e-05	0.000374	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	1.89e-05	0.00199	CbGpPWpGaD
Ramipril—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.88e-05	0.000374	CcSEcCtD
Ramipril—Paraesthesia—Metformin—type 2 diabetes mellitus	1.88e-05	0.000374	CcSEcCtD
Ramipril—Confusional state—Losartan—type 2 diabetes mellitus	1.88e-05	0.000373	CcSEcCtD
Ramipril—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.88e-05	0.000372	CcSEcCtD
Ramipril—Dyspnoea—Metformin—type 2 diabetes mellitus	1.87e-05	0.000371	CcSEcCtD
Ramipril—Somnolence—Metformin—type 2 diabetes mellitus	1.87e-05	0.00037	CcSEcCtD
Ramipril—Oedema—Losartan—type 2 diabetes mellitus	1.86e-05	0.00037	CcSEcCtD
Ramipril—Anaphylactic shock—Losartan—type 2 diabetes mellitus	1.86e-05	0.00037	CcSEcCtD
Ramipril—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.86e-05	0.000369	CcSEcCtD
Ramipril—Hypotension—Irbesartan—type 2 diabetes mellitus	1.85e-05	0.000367	CcSEcCtD
Ramipril—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.85e-05	0.000367	CcSEcCtD
Ramipril—Dyspepsia—Metformin—type 2 diabetes mellitus	1.85e-05	0.000366	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.84e-05	0.00194	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—OXCT1—type 2 diabetes mellitus	1.84e-05	0.00194	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.84e-05	0.00194	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.84e-05	0.00194	CbGpPWpGaD
Ramipril—Shock—Losartan—type 2 diabetes mellitus	1.83e-05	0.000364	CcSEcCtD
Ramipril—Urticaria—Valsartan—type 2 diabetes mellitus	1.83e-05	0.000363	CcSEcCtD
Ramipril—Nervous system disorder—Losartan—type 2 diabetes mellitus	1.83e-05	0.000363	CcSEcCtD
Ramipril—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.83e-05	0.000362	CcSEcCtD
Ramipril—Decreased appetite—Metformin—type 2 diabetes mellitus	1.82e-05	0.000362	CcSEcCtD
Ramipril—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.82e-05	0.000361	CcSEcCtD
Ramipril—Tachycardia—Losartan—type 2 diabetes mellitus	1.82e-05	0.000361	CcSEcCtD
Ramipril—Nausea—Bromocriptine—type 2 diabetes mellitus	1.82e-05	0.00036	CcSEcCtD
Ramipril—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.81e-05	0.000359	CcSEcCtD
Ramipril—Fatigue—Metformin—type 2 diabetes mellitus	1.81e-05	0.000359	CcSEcCtD
Ramipril—Urticaria—Orlistat—type 2 diabetes mellitus	1.81e-05	0.000359	CcSEcCtD
Ramipril—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.8e-05	0.000358	CcSEcCtD
Ramipril—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.8e-05	0.000357	CcSEcCtD
Ramipril—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.8e-05	0.000357	CcSEcCtD
Ramipril—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.8e-05	0.000357	CcSEcCtD
Ramipril—Asthenia—Gliclazide—type 2 diabetes mellitus	1.8e-05	0.000357	CcSEcCtD
Ramipril—Constipation—Metformin—type 2 diabetes mellitus	1.79e-05	0.000356	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SRD5A1—type 2 diabetes mellitus	1.79e-05	0.00189	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.78e-05	0.00188	CbGpPWpGaD
Ramipril—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.78e-05	0.000353	CcSEcCtD
Ramipril—Anorexia—Losartan—type 2 diabetes mellitus	1.78e-05	0.000352	CcSEcCtD
Ramipril—Vomiting—Glyburide—type 2 diabetes mellitus	1.78e-05	0.000352	CcSEcCtD
Ramipril—Pruritus—Gliclazide—type 2 diabetes mellitus	1.77e-05	0.000352	CcSEcCtD
Ramipril—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.77e-05	0.00035	CcSEcCtD
Ramipril—Rash—Glyburide—type 2 diabetes mellitus	1.76e-05	0.000349	CcSEcCtD
Ramipril—Somnolence—Irbesartan—type 2 diabetes mellitus	1.76e-05	0.000349	CcSEcCtD
Ramipril—Dermatitis—Glyburide—type 2 diabetes mellitus	1.76e-05	0.000349	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	1.75e-05	0.00185	CbGpPWpGaD
Ramipril—Headache—Glyburide—type 2 diabetes mellitus	1.75e-05	0.000347	CcSEcCtD
Ramipril—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.74e-05	0.000346	CcSEcCtD
Ramipril—Hypotension—Losartan—type 2 diabetes mellitus	1.74e-05	0.000345	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	1.74e-05	0.00183	CbGpPWpGaD
Ramipril—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.73e-05	0.000343	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—GCG—type 2 diabetes mellitus	1.72e-05	0.00182	CbGpPWpGaD
Ramipril—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.72e-05	0.000341	CcSEcCtD
Ramipril—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.72e-05	0.00034	CcSEcCtD
Ramipril—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.72e-05	0.00034	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—STAR—type 2 diabetes mellitus	1.71e-05	0.0018	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD17B3—type 2 diabetes mellitus	1.71e-05	0.0018	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ACACA—type 2 diabetes mellitus	1.71e-05	0.0018	CbGpPWpGaD
Ramipril—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.71e-05	0.000339	CcSEcCtD
Ramipril—Fatigue—Irbesartan—type 2 diabetes mellitus	1.71e-05	0.000339	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.71e-05	0.0018	CbGpPWpGaD
Ramipril—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.7e-05	0.000337	CcSEcCtD
Ramipril—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.7e-05	0.000337	CcSEcCtD
Ramipril—Constipation—Irbesartan—type 2 diabetes mellitus	1.69e-05	0.000336	CcSEcCtD
Ramipril—Insomnia—Losartan—type 2 diabetes mellitus	1.69e-05	0.000334	CcSEcCtD
Ramipril—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.68e-05	0.000333	CcSEcCtD
Ramipril—Paraesthesia—Losartan—type 2 diabetes mellitus	1.67e-05	0.000332	CcSEcCtD
Ramipril—Urticaria—Metformin—type 2 diabetes mellitus	1.67e-05	0.000331	CcSEcCtD
Ramipril—Dyspnoea—Losartan—type 2 diabetes mellitus	1.66e-05	0.00033	CcSEcCtD
Ramipril—Nausea—Glyburide—type 2 diabetes mellitus	1.66e-05	0.000329	CcSEcCtD
Ramipril—Abdominal pain—Metformin—type 2 diabetes mellitus	1.66e-05	0.000329	CcSEcCtD
Ramipril—Dizziness—Gliclazide—type 2 diabetes mellitus	1.66e-05	0.000329	CcSEcCtD
Ramipril—Somnolence—Losartan—type 2 diabetes mellitus	1.66e-05	0.000329	CcSEcCtD
Ramipril—Asthenia—Valsartan—type 2 diabetes mellitus	1.65e-05	0.000328	CcSEcCtD
Ramipril—Dyspepsia—Losartan—type 2 diabetes mellitus	1.64e-05	0.000325	CcSEcCtD
Ramipril—BCHE—Neuronal System—SNAP25—type 2 diabetes mellitus	1.63e-05	0.00172	CbGpPWpGaD
Ramipril—Asthenia—Orlistat—type 2 diabetes mellitus	1.63e-05	0.000324	CcSEcCtD
Ramipril—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.63e-05	0.000324	CcSEcCtD
Ramipril—Pruritus—Valsartan—type 2 diabetes mellitus	1.63e-05	0.000323	CcSEcCtD
Ramipril—Decreased appetite—Losartan—type 2 diabetes mellitus	1.62e-05	0.000321	CcSEcCtD
Ramipril—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.62e-05	0.000321	CcSEcCtD
Ramipril—Pruritus—Orlistat—type 2 diabetes mellitus	1.61e-05	0.00032	CcSEcCtD
Ramipril—Fatigue—Losartan—type 2 diabetes mellitus	1.61e-05	0.000319	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.6e-05	0.00168	CbGpPWpGaD
Ramipril—Vomiting—Gliclazide—type 2 diabetes mellitus	1.6e-05	0.000316	CcSEcCtD
Ramipril—Constipation—Losartan—type 2 diabetes mellitus	1.59e-05	0.000316	CcSEcCtD
Ramipril—BCHE—Transmission across Chemical Synapses—GNB3—type 2 diabetes mellitus	1.59e-05	0.00168	CbGpPWpGaD
Ramipril—Rash—Gliclazide—type 2 diabetes mellitus	1.58e-05	0.000314	CcSEcCtD
Ramipril—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.58e-05	0.000313	CcSEcCtD
Ramipril—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.58e-05	0.000313	CcSEcCtD
Ramipril—Urticaria—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000312	CcSEcCtD
Ramipril—Headache—Gliclazide—type 2 diabetes mellitus	1.57e-05	0.000312	CcSEcCtD
Ramipril—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000311	CcSEcCtD
Ramipril—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000311	CcSEcCtD
Ramipril—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.56e-05	0.000309	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—NCOA6—type 2 diabetes mellitus	1.55e-05	0.00164	CbGpPWpGaD
Ramipril—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.54e-05	0.000305	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD11B1—type 2 diabetes mellitus	1.53e-05	0.00161	CbGpPWpGaD
Ramipril—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.52e-05	0.000302	CcSEcCtD
Ramipril—Dizziness—Valsartan—type 2 diabetes mellitus	1.52e-05	0.000302	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.52e-05	0.00161	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.52e-05	0.00161	CbGpPWpGaD
Ramipril—Dizziness—Orlistat—type 2 diabetes mellitus	1.51e-05	0.000299	CcSEcCtD
Ramipril—Asthenia—Metformin—type 2 diabetes mellitus	1.51e-05	0.000299	CcSEcCtD
Ramipril—Nausea—Gliclazide—type 2 diabetes mellitus	1.49e-05	0.000296	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.49e-05	0.00157	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	1.49e-05	0.00157	CbGpPWpGaD
Ramipril—Pruritus—Metformin—type 2 diabetes mellitus	1.49e-05	0.000295	CcSEcCtD
Ramipril—Urticaria—Losartan—type 2 diabetes mellitus	1.48e-05	0.000294	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.48e-05	0.00156	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.48e-05	0.00156	CbGpPWpGaD
Ramipril—Nateglinide—CYP3A4—type 2 diabetes mellitus	1.47e-05	0.0113	CrCbGaD
Ramipril—Abdominal pain—Losartan—type 2 diabetes mellitus	1.47e-05	0.000292	CcSEcCtD
Ramipril—Body temperature increased—Losartan—type 2 diabetes mellitus	1.47e-05	0.000292	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.47e-05	0.00155	CbGpPWpGaD
Ramipril—Vomiting—Valsartan—type 2 diabetes mellitus	1.47e-05	0.000291	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	1.46e-05	0.00154	CbGpPWpGaD
Ramipril—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.46e-05	0.000289	CcSEcCtD
Ramipril—Rash—Valsartan—type 2 diabetes mellitus	1.45e-05	0.000288	CcSEcCtD
Ramipril—Dermatitis—Valsartan—type 2 diabetes mellitus	1.45e-05	0.000288	CcSEcCtD
Ramipril—Vomiting—Orlistat—type 2 diabetes mellitus	1.45e-05	0.000287	CcSEcCtD
Ramipril—Headache—Valsartan—type 2 diabetes mellitus	1.44e-05	0.000286	CcSEcCtD
Ramipril—Diarrhoea—Metformin—type 2 diabetes mellitus	1.44e-05	0.000285	CcSEcCtD
Ramipril—Rash—Orlistat—type 2 diabetes mellitus	1.44e-05	0.000285	CcSEcCtD
Ramipril—Dermatitis—Orlistat—type 2 diabetes mellitus	1.43e-05	0.000285	CcSEcCtD
Ramipril—Headache—Orlistat—type 2 diabetes mellitus	1.43e-05	0.000283	CcSEcCtD
Ramipril—Asthenia—Irbesartan—type 2 diabetes mellitus	1.42e-05	0.000282	CcSEcCtD
Ramipril—BCHE—Transmission across Chemical Synapses—ADCY5—type 2 diabetes mellitus	1.42e-05	0.0015	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	1.42e-05	0.0015	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	1.42e-05	0.0015	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.41e-05	0.00149	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.41e-05	0.00149	CbGpPWpGaD
Ramipril—Pruritus—Irbesartan—type 2 diabetes mellitus	1.4e-05	0.000278	CcSEcCtD
Ramipril—Dizziness—Metformin—type 2 diabetes mellitus	1.39e-05	0.000275	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.38e-05	0.00146	CbGpPWpGaD
Ramipril—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.37e-05	0.000272	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.37e-05	0.00145	CbGpPWpGaD
Ramipril—Nausea—Valsartan—type 2 diabetes mellitus	1.37e-05	0.000272	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—GIP—type 2 diabetes mellitus	1.36e-05	0.00144	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.36e-05	0.00144	CbGpPWpGaD
Ramipril—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.36e-05	0.000269	CcSEcCtD
Ramipril—Nausea—Orlistat—type 2 diabetes mellitus	1.35e-05	0.000268	CcSEcCtD
Ramipril—Asthenia—Losartan—type 2 diabetes mellitus	1.34e-05	0.000265	CcSEcCtD
Ramipril—Vomiting—Metformin—type 2 diabetes mellitus	1.33e-05	0.000265	CcSEcCtD
Ramipril—Rash—Metformin—type 2 diabetes mellitus	1.32e-05	0.000262	CcSEcCtD
Ramipril—Dermatitis—Metformin—type 2 diabetes mellitus	1.32e-05	0.000262	CcSEcCtD
Ramipril—Pruritus—Losartan—type 2 diabetes mellitus	1.32e-05	0.000262	CcSEcCtD
Ramipril—BCHE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	1.32e-05	0.00139	CbGpPWpGaD
Ramipril—Headache—Metformin—type 2 diabetes mellitus	1.31e-05	0.000261	CcSEcCtD
Ramipril—Dizziness—Irbesartan—type 2 diabetes mellitus	1.31e-05	0.00026	CcSEcCtD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LPA—type 2 diabetes mellitus	1.3e-05	0.00137	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HSD3B2—type 2 diabetes mellitus	1.3e-05	0.00137	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.3e-05	0.00137	CbGpPWpGaD
Ramipril—Nateglinide—ALB—type 2 diabetes mellitus	1.29e-05	0.00986	CrCbGaD
Ramipril—BCHE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	1.28e-05	0.00135	CbGpPWpGaD
Ramipril—Diarrhoea—Losartan—type 2 diabetes mellitus	1.28e-05	0.000253	CcSEcCtD
Ramipril—BCHE—Metabolism—BHMT—type 2 diabetes mellitus	1.27e-05	0.00134	CbGpPWpGaD
Ramipril—Vomiting—Irbesartan—type 2 diabetes mellitus	1.26e-05	0.00025	CcSEcCtD
Ramipril—Rash—Irbesartan—type 2 diabetes mellitus	1.25e-05	0.000248	CcSEcCtD
Ramipril—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.25e-05	0.000247	CcSEcCtD
Ramipril—Nausea—Metformin—type 2 diabetes mellitus	1.25e-05	0.000247	CcSEcCtD
Ramipril—Headache—Irbesartan—type 2 diabetes mellitus	1.24e-05	0.000246	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.24e-05	0.0013	CbGpPWpGaD
Ramipril—Dizziness—Losartan—type 2 diabetes mellitus	1.23e-05	0.000244	CcSEcCtD
Ramipril—BCHE—Phospholipid metabolism—PIK3R1—type 2 diabetes mellitus	1.23e-05	0.00129	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—GNB3—type 2 diabetes mellitus	1.22e-05	0.00129	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—CALM1—type 2 diabetes mellitus	1.22e-05	0.00129	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.2e-05	0.00127	CbGpPWpGaD
Ramipril—SLC15A2—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.2e-05	0.00127	CbGpPWpGaD
Ramipril—Vomiting—Losartan—type 2 diabetes mellitus	1.19e-05	0.000235	CcSEcCtD
Ramipril—SLC15A2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.18e-05	0.00125	CbGpPWpGaD
Ramipril—Nausea—Irbesartan—type 2 diabetes mellitus	1.18e-05	0.000233	CcSEcCtD
Ramipril—Rash—Losartan—type 2 diabetes mellitus	1.18e-05	0.000233	CcSEcCtD
Ramipril—Dermatitis—Losartan—type 2 diabetes mellitus	1.17e-05	0.000233	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	1.17e-05	0.00124	CbGpPWpGaD
Ramipril—Headache—Losartan—type 2 diabetes mellitus	1.17e-05	0.000232	CcSEcCtD
Ramipril—ACE—Metabolism of proteins—AGT—type 2 diabetes mellitus	1.16e-05	0.00122	CbGpPWpGaD
Ramipril—BCHE—Transmission across Chemical Synapses—PRKCB—type 2 diabetes mellitus	1.15e-05	0.00121	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.15e-05	0.00121	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—LEP—type 2 diabetes mellitus	1.13e-05	0.0012	CbGpPWpGaD
Ramipril—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.11e-05	0.00118	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTGDS—type 2 diabetes mellitus	1.11e-05	0.00117	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AANAT—type 2 diabetes mellitus	1.11e-05	0.00117	CbGpPWpGaD
Ramipril—Nausea—Losartan—type 2 diabetes mellitus	1.11e-05	0.00022	CcSEcCtD
Ramipril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.1e-05	0.00116	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—ADCY5—type 2 diabetes mellitus	1.09e-05	0.00115	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CPT1A—type 2 diabetes mellitus	1.06e-05	0.00111	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CDO1—type 2 diabetes mellitus	1.05e-05	0.00111	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GPD2—type 2 diabetes mellitus	1.05e-05	0.00111	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LIPC—type 2 diabetes mellitus	1.03e-05	0.00109	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP11A1—type 2 diabetes mellitus	1.02e-05	0.00108	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.02e-05	0.00108	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1.02e-05	0.00107	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	1.01e-05	0.00106	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AK1—type 2 diabetes mellitus	1.01e-05	0.00106	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CETP—type 2 diabetes mellitus	9.94e-06	0.00105	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.73e-06	0.00103	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—INS—type 2 diabetes mellitus	9.69e-06	0.00102	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	9.54e-06	0.00101	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	9.48e-06	0.000999	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	9.46e-06	0.000998	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	9.43e-06	0.000995	CbGpPWpGaD
Ramipril—ACE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	9.37e-06	0.000989	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—CALM1—type 2 diabetes mellitus	9.35e-06	0.000986	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.35e-06	0.000986	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MAT1A—type 2 diabetes mellitus	9.28e-06	0.000979	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC5A4—type 2 diabetes mellitus	9.28e-06	0.000979	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—SREBF1—type 2 diabetes mellitus	9.24e-06	0.000975	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	9.1e-06	0.00096	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CTGF—type 2 diabetes mellitus	9.07e-06	0.000957	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.03e-06	0.000953	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—HMGCR—type 2 diabetes mellitus	8.99e-06	0.000948	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPP1R3C—type 2 diabetes mellitus	8.96e-06	0.000945	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ND1—type 2 diabetes mellitus	8.96e-06	0.000945	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ENPP1—type 2 diabetes mellitus	8.96e-06	0.000945	CbGpPWpGaD
Ramipril—BCHE—Metabolism—G6PC—type 2 diabetes mellitus	8.96e-06	0.000945	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HBA2—type 2 diabetes mellitus	8.96e-06	0.000945	CbGpPWpGaD
Ramipril—BCHE—Neuronal System—PRKCB—type 2 diabetes mellitus	8.79e-06	0.000927	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GCGR—type 2 diabetes mellitus	8.68e-06	0.000915	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—F7—type 2 diabetes mellitus	8.49e-06	0.000896	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.45e-06	0.000891	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	8.36e-06	0.000881	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	8.27e-06	0.000872	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.21e-06	0.000866	CbGpPWpGaD
Ramipril—BCHE—Metabolism—OXCT1—type 2 diabetes mellitus	8.2e-06	0.000865	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYTB—type 2 diabetes mellitus	8.2e-06	0.000865	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SRD5A1—type 2 diabetes mellitus	7.99e-06	0.000843	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.7e-06	0.000812	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ACACA—type 2 diabetes mellitus	7.62e-06	0.000804	CbGpPWpGaD
Ramipril—BCHE—Metabolism—STAR—type 2 diabetes mellitus	7.62e-06	0.000804	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD17B3—type 2 diabetes mellitus	7.62e-06	0.000804	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	7.62e-06	0.000804	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	7.57e-06	0.000798	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—ACE—type 2 diabetes mellitus	7.33e-06	0.000773	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CBS—type 2 diabetes mellitus	7.31e-06	0.000771	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ABCC8—type 2 diabetes mellitus	7.31e-06	0.000771	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.15e-06	0.000754	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	7.04e-06	0.000743	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC5A2—type 2 diabetes mellitus	7.03e-06	0.000742	CbGpPWpGaD
Ramipril—BCHE—Metabolism—COX2—type 2 diabetes mellitus	7.03e-06	0.000742	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—GCG—type 2 diabetes mellitus	6.92e-06	0.00073	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NCOA6—type 2 diabetes mellitus	6.91e-06	0.000729	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	6.91e-06	0.000728	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UCP3—type 2 diabetes mellitus	6.79e-06	0.000716	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD11B1—type 2 diabetes mellitus	6.79e-06	0.000716	CbGpPWpGaD
Ramipril—BCHE—Metabolism—UCP2—type 2 diabetes mellitus	6.79e-06	0.000716	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	6.58e-06	0.000694	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PCK1—type 2 diabetes mellitus	6.39e-06	0.000674	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	6.29e-06	0.000663	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	6.13e-06	0.000647	CbGpPWpGaD
Ramipril—SLC15A2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.1e-06	0.000644	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HK1—type 2 diabetes mellitus	5.98e-06	0.000631	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	5.97e-06	0.00063	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	5.97e-06	0.000629	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	5.86e-06	0.000618	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HSD3B2—type 2 diabetes mellitus	5.78e-06	0.000609	CbGpPWpGaD
Ramipril—BCHE—Metabolism—KCNJ11—type 2 diabetes mellitus	5.78e-06	0.000609	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LPA—type 2 diabetes mellitus	5.78e-06	0.000609	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GCKR—type 2 diabetes mellitus	5.78e-06	0.000609	CbGpPWpGaD
Ramipril—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	5.66e-06	0.000597	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	5.55e-06	0.000586	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ALDOB—type 2 diabetes mellitus	5.54e-06	0.000584	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	5.38e-06	0.000567	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	5.27e-06	0.000556	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	5.21e-06	0.000549	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GLP1R—type 2 diabetes mellitus	5.15e-06	0.000543	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC2A2—type 2 diabetes mellitus	4.81e-06	0.000507	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CPT1A—type 2 diabetes mellitus	4.71e-06	0.000497	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MTR—type 2 diabetes mellitus	4.71e-06	0.000497	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	4.71e-06	0.000496	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—AGT—type 2 diabetes mellitus	4.65e-06	0.00049	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NAMPT—type 2 diabetes mellitus	4.62e-06	0.000487	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	4.59e-06	0.000484	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LIPC—type 2 diabetes mellitus	4.59e-06	0.000484	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HBA1—type 2 diabetes mellitus	4.59e-06	0.000484	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GCK—type 2 diabetes mellitus	4.59e-06	0.000484	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP11A1—type 2 diabetes mellitus	4.56e-06	0.000481	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—LEP—type 2 diabetes mellitus	4.55e-06	0.00048	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC9A1—type 2 diabetes mellitus	4.48e-06	0.000472	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CETP—type 2 diabetes mellitus	4.43e-06	0.000467	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	4.13e-06	0.000435	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PSMD6—type 2 diabetes mellitus	4.12e-06	0.000434	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SNAP25—type 2 diabetes mellitus	4.12e-06	0.000434	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SREBF1—type 2 diabetes mellitus	4.12e-06	0.000434	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CTGF—type 2 diabetes mellitus	4.04e-06	0.000426	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HMGCR—type 2 diabetes mellitus	4e-06	0.000422	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	3.95e-06	0.000416	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ADRA2A—type 2 diabetes mellitus	3.92e-06	0.000413	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—INS—type 2 diabetes mellitus	3.89e-06	0.00041	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	3.83e-06	0.000404	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP2E1—type 2 diabetes mellitus	3.76e-06	0.000397	CbGpPWpGaD
Ramipril—BCHE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	3.76e-06	0.000397	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP1A2—type 2 diabetes mellitus	3.72e-06	0.000393	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC2A1—type 2 diabetes mellitus	3.72e-06	0.000393	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CYP3A4—type 2 diabetes mellitus	3.63e-06	0.000383	CbGpPWpGaD
Ramipril—BCHE—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	3.61e-06	0.000381	CbGpPWpGaD
Ramipril—BCHE—Metabolism—SLC2A4—type 2 diabetes mellitus	3.57e-06	0.000376	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GCG—type 2 diabetes mellitus	3.57e-06	0.000376	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPARGC1A—type 2 diabetes mellitus	3.08e-06	0.000324	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GNB3—type 2 diabetes mellitus	3.08e-06	0.000324	CbGpPWpGaD
Ramipril—BCHE—Metabolism—HMOX1—type 2 diabetes mellitus	3.06e-06	0.000323	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CAT—type 2 diabetes mellitus	3.02e-06	0.000319	CbGpPWpGaD
Ramipril—BCHE—Metabolism—APOB—type 2 diabetes mellitus	2.93e-06	0.000309	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GSTM1—type 2 diabetes mellitus	2.85e-06	0.000301	CbGpPWpGaD
Ramipril—BCHE—Metabolism—LPL—type 2 diabetes mellitus	2.8e-06	0.000295	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ADCY5—type 2 diabetes mellitus	2.74e-06	0.000289	CbGpPWpGaD
Ramipril—BCHE—Metabolism—GPX1—type 2 diabetes mellitus	2.73e-06	0.000288	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CD36—type 2 diabetes mellitus	2.66e-06	0.000281	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPP2CA—type 2 diabetes mellitus	2.63e-06	0.000277	CbGpPWpGaD
Ramipril—BCHE—Metabolism—MTHFR—type 2 diabetes mellitus	2.52e-06	0.000266	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPARA—type 2 diabetes mellitus	2.47e-06	0.000261	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AGT—type 2 diabetes mellitus	2.4e-06	0.000253	CbGpPWpGaD
Ramipril—BCHE—Metabolism—CALM1—type 2 diabetes mellitus	2.36e-06	0.000248	CbGpPWpGaD
Ramipril—BCHE—Metabolism—APOE—type 2 diabetes mellitus	2.35e-06	0.000248	CbGpPWpGaD
Ramipril—BCHE—Metabolism—APOA1—type 2 diabetes mellitus	2.32e-06	0.000245	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PPARG—type 2 diabetes mellitus	2.04e-06	0.000216	CbGpPWpGaD
Ramipril—BCHE—Metabolism—INS—type 2 diabetes mellitus	2e-06	0.000211	CbGpPWpGaD
Ramipril—BCHE—Metabolism—ALB—type 2 diabetes mellitus	1.84e-06	0.000194	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PIK3R1—type 2 diabetes mellitus	1.76e-06	0.000185	CbGpPWpGaD
Ramipril—BCHE—Metabolism—NOS3—type 2 diabetes mellitus	1.76e-06	0.000185	CbGpPWpGaD
Ramipril—BCHE—Metabolism—PTGS2—type 2 diabetes mellitus	1.61e-06	0.00017	CbGpPWpGaD
Ramipril—BCHE—Metabolism—AKT1—type 2 diabetes mellitus	8.08e-07	8.52e-05	CbGpPWpGaD
